vopimetostat

News

A study of RevMed's Rasonque with Tango's vopimetostat has raised hopes of a new combination therapy for aggressive pancreatic cancer.

News

Takeda and Innovent's CLDN18.2-targeting ADC, arcotatug tavatecan, will be filed in Japan on the back of positive survival data in gastric cancer.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.